Cardiovascular disease often advances without obvious warning, driven in part by the gradual accumulation of low-density lipoprotein (LDL) cholesterol within arterial walls. Over time, this buildup ...

Alumni Endowed Professor of Pathology and Immunology, Division of Laboratory and Genomic Medicine, Department of Pathology and Immunology, Washington University School of Medicine RNA viruses use a ...

The results of a phase three clinical trial for a cholesterol-lowering drug have shown that this drug can reduce the levels ...

A once-a-day tablet called enlicitide is reshaping expectations for cholesterol care, cutting low density lipoprotein, or ...

PHILADELPHIA ­— Ten patients enrolled in the experimental drug trial, and they were the sickest of the sick. All had a genetic disorder that cranks up levels of LDL cholesterol in the blood. Known as ...

Patients with severe hypercholesterolemia who are unresponsive to a number of lipid-lowering therapies, including a PCSK9 inhibitor and high-dose statin, can have a significant reduction in ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

Cholesterol has a bad reputation, and statins are often seen as the only solution. But one doctor has said that many people can lower their cholesterol without medication.